Evidence map›Paper›PMID 38352760›Full record

ArticleHeliyon2024

Plasticizer-gelatin mixed solutions as skin protection materials with flexible-film-forming capability.

Shunji Yunoki, Asami Mogi, Keizo Mizuno, Yoshiyasu Nagakawa, Yosuke Hiraoka

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shunji YunokiInstitute for the Promotion of Business-Regional Collaboration, Hokkaido University, Kita-21, Nishi-11, Kita-ku, Sapporo, Hokkaido, 001-0021, Japan.
Asami MogiNew Business Planning and Research Section, Shin Nippon Yakugyo Co., Ltd, 15-10 Nihonbashi-Kodenmacho, Chuo-Ku, Tokyo, 103-0001, Japan.
Keizo MizunoNew Business Planning and Research Section, Shin Nippon Yakugyo Co., Ltd, 15-10 Nihonbashi-Kodenmacho, Chuo-Ku, Tokyo, 103-0001, Japan.
Yoshiyasu NagakawaBiotechnology Group, Tokyo Metropolitan Industrial Technology Research Institute (TIRI), 2-4-10 Aomi, Koto-ku, Tokyo, 135-0064, Japan.
Yosuke HiraokaBiomedical Department, R&D Center, Nitta Gelatin Inc., 2-22, Futamata, Yao City, Osaka, 581-0024, Japan.
Hokkaido University · JPTokyo Metropolitan Industrial Technology Research Institute · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To demonstrate the feasibility of plasticizer-gelatin solutions as novel skin protection materials from a physical aspect, we evaluated the rheological properties of the solutions and the mechanical properties and textures of their dried sheets and films. Three types of sugars and polyols were employed as organic plasticizers and mixed with gelatin in solutions at plasticizer/gelatin weight ratios of 0.13-1.67. The plasticizers minimally affected the viscosities and gelation temperatures of the gelatin solutions, but they remarkably softened dried gelatin sheets, except for propylene glycol. Glycerol exhibited the best plasticizing effects, but the sheets obtained using glycerol showed tacky textures. Preliminary investigations on the film-forming properties of the solutions on the human skin showed that the fructose-gelatin solution at a weight ratio of 1.0 formed a flexible thin film with a texture and mechanical properties similar to those of a commercially available polyurethane-based flexible film dressing. In terms of physical properties, we conclude that the fructose-gelatin solution has potential as a skin protection material that transforms from a solution to a film on the skin.

Indexed as

GelatinGelationPlasticizerSkinSugar

Identifiers

PMID38352760
PMCPMC10862670
OpenAlexW4391319026

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.